R&D Process

MMV’s science portfolio is the most robust and diverse portfolio of antimalarial drug projects in history. Our ultimate goal is to build a strong pipeline of molecules leading to a new generation of medicines that will form a critical part of the arsenal needed to eradicate malaria. The process to discover and develop a new antimalarial ready to be delivered to those in need normally takes between 13-15 years.